Lung Cancer ICD-10 is the standardized coding system used to classify and document lung cancer in medical records. At CIMS Bhopal (Career Institute of Medical Sciences), these codes support accurate diagnosis, treatment planning, insurance claims, and effective communication among healthcare professionals.

The primary ICD-10 code for lung cancer is C34 – Malignant Neoplasm of Bronchus and Lung. Depending on where the cancer develops within the lungs, more specific subcodes are assigned. While these codes may appear on medical reports or hospital documents, they simply help identify the location of the cancer and do not indicate its type or stage.

This guide explains Lung Cancer ICD-10 codes in simple terms, along with the types of lung cancer, common symptoms, diagnosis, and available treatment options.

What Is the ICD-10 Code for Lung Cancer?

The ICD-10 code for lung cancer is C34 – Malignant Neoplasm of Bronchus and Lung. It is the standard code used by hospitals and healthcare providers to record a diagnosis of lung cancer. This code appears in medical records, discharge summaries, insurance documents, and hospital billing systems.

Since lung cancer can develop in different parts of the lungs, the C34 category is further divided into more specific codes based on the tumour's location.

For example, if a tumour is found in the right upper lobe (RUL) of the lung, it is generally classified under C34.1. Similarly, cancer affecting the left lower lobe (LLL) is usually coded as C34.3. If the exact location of the tumour has not yet been determined, doctors may use C34.9 (unspecified lung cancer) until further investigations are completed.

It is important to understand that ICD-10 codes identify the location of the cancer, not its stage or severity. Details such as whether the cancer is non-small cell lung cancer, small cell lung cancer, or Stage 4 lung cancer are recorded separately in the patient's clinical diagnosis.

Types of Lung Cancer and Their ICD-10 Classification

Although the Lung Cancer ICD-10 code identifies where the cancer is located, doctors also classify lung cancer based on the type of cells involved. This classification helps determine the most appropriate treatment and gives a better understanding of how the disease may behave.

The most common type is Non-Small Cell Lung Cancer (NSCLC), which accounts for about 85% of all lung cancer cases. It includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. While many people search for a separate Non-Small Cell Lung Cancer ICD-10 code, there isn't one. Instead, the ICD-10 code is assigned according to the location of the tumour, while the pathology report confirms the cancer type.

The second major type is Small Cell Lung Cancer (SCLC), a less common but more aggressive form of lung cancer that tends to grow and spread rapidly. Like NSCLC, it is coded under the appropriate C34 category based on where the tumour originates in the lung.

Another commonly searched term is Metastatic Lung Cancer ICD-10. Metastatic lung cancer refers to cancer that has spread from the lungs to other parts of the body, such as the brain, liver, bones, or adrenal glands. In these cases, doctors use the primary C34 code for the lung cancer along with additional ICD-10 codes to identify the organs affected by the spread.

Similarly, many people look for a Stage 4 Lung Cancer ICD-10 code. However, ICD-10 codes do not indicate the stage of cancer. The stage is determined separately using imaging tests and the TNM staging system, which assesses the size of the tumour, lymph node involvement, and whether the cancer has spread to distant organs. Therefore, two patients may have the same ICD-10 code but different stages of lung cancer depending on the extent of the disease.

Symptoms, Risk Factors, and Diagnosis of Lung Cancer

Lung cancer often develops without noticeable symptoms in its early stages, making regular health check-ups important for people at high risk. As the disease progresses, several warning signs may appear.

Common Symptoms of Lung Cancer 

• A persistent cough that lasts for more than three weeks or continues to worsen should be evaluated by a doctor.

• Chest pain may occur during breathing, coughing, or everyday activities as the tumour grows.

• Coughing up blood (hemoptysis) is a serious symptom that requires immediate medical attention.

• Shortness of breath may develop when the tumour blocks the airways or affects lung function.

• Hoarseness or wheezing can occur if the cancer affects the vocal cords or air passages.

• Unexplained weight loss and fatigue are common symptoms, particularly in advanced stages of lung cancer.

• Frequent chest infections, such as bronchitis or pneumonia, may sometimes indicate an underlying lung problem.

Risk Factors for Lung Cancer 

Although smoking is the leading cause of lung cancer, several other factors can also increase the risk.

• Smoking tobacco remains the most significant risk factor and is responsible for the majority of lung cancer cases.

• Exposure to secondhand smoke can increase the risk even in people who have never smoked.

• Long-term exposure to air pollution, radon gas, asbestos, silica, or industrial chemicals may contribute to the development of lung cancer.

• A family history of lung cancer may increase the likelihood of developing the disease.

• Previous radiation therapy to the chest can slightly raise the risk later in life.

How Is Lung Cancer Diagnosed?

If lung cancer is suspected, doctors recommend a series of tests to confirm the diagnosis and determine the stage of the disease.

• A chest X-ray is often the first imaging test used to detect abnormalities in the lungs.

• A CT scan provides detailed images and helps identify the size, location, and extent of the tumour.

• A PET-CT scan is performed to determine whether the cancer has spread to lymph nodes or other organs.

• Bronchoscopy allows doctors to examine the airways and collect tissue samples when needed.

• A biopsy is the most reliable test for confirming lung cancer, as it allows the tissue to be examined under a microscope.

• Molecular or genetic testing may be recommended to identify specific mutations that can guide targeted therapy.

Early diagnosis significantly improves the chances of successful treatment. Anyone experiencing persistent symptoms or having significant risk factors should consult a qualified healthcare professional without delay.

Treatment Options for Lung Cancer

The treatment for lung cancer depends on several factors, including the type of lung cancer, its stage, the patient's overall health, and whether the cancer has spread. After a thorough evaluation, doctors develop a personalized treatment plan to achieve the best possible outcome.

• Surgery is often recommended for early-stage lung cancer when the tumour is confined to the lung. Depending on the size and location of the tumour, the surgeon may remove a small section of the lung, an entire lobe, or, in some cases, the entire lung.

• Radiation therapy uses high-energy radiation to destroy cancer cells. It may be used as the primary treatment, before surgery to shrink a tumour, or after surgery to reduce the risk of recurrence.

• Chemotherapy uses anti-cancer medicines to destroy rapidly growing cancer cells. It is commonly used for advanced lung cancer or in combination with surgery and radiation therapy.

• Targeted therapy is recommended for patients whose cancer has specific genetic mutations, such as EGFR or ALK alterations. These medicines target cancer cells more precisely while minimizing damage to healthy tissues.

• Immunotherapy helps the body's immune system recognize and attack cancer cells. It has become an important treatment option for many patients with advanced non-small cell lung cancer.

• Palliative care focuses on relieving symptoms such as pain, breathlessness, fatigue, and improving quality of life. It can be provided alongside active cancer treatment at any stage of the disease.

At CIMS Bhopal, lung cancer treatment is delivered by a multidisciplinary team of pulmonologists, medical oncologists, radiation oncologists, thoracic surgeons, radiologists, pathologists, and supportive care specialists. Every treatment plan is tailored to the patient's diagnosis, stage of cancer, and individual health needs.

Frequently Asked Questions (FAQs)

What is the ICD-10 code for lung cancer?

The primary ICD-10 code for lung cancer is C34 – Malignant Neoplasm of Bronchus and Lung. Additional subcodes identify the exact location of the tumour within the lungs.

What is the ICD-10 code for Stage 4 lung cancer?

There is no separate ICD-10 code for Stage 4 lung cancer. The C34 code identifies where the cancer started, while the stage is determined using the TNM staging system.

What is the ICD-10 code for metastatic lung cancer?

Metastatic lung cancer is coded using the primary C34 code for the lung tumour along with additional ICD-10 codes that identify the organs where the cancer has spread.

What is the ICD-10 code for non-small cell lung cancer?

Non-small cell lung cancer does not have a separate ICD-10 code. It is coded under the C34 category according to the tumour's location, while the pathology report specifies the cancer type.

How is lung cancer diagnosed?

Lung cancer is diagnosed using a combination of imaging tests such as chest X-rays, CT scans, PET-CT scans, bronchoscopy, biopsy, and molecular testing to confirm the diagnosis and determine the stage.

Understanding the Lung Cancer ICD-10 code can make medical reports easier to interpret and helps patients understand how lung cancer is documented in healthcare settings. While the C34 code identifies the location of the cancer, factors such as the cancer type, stage, and overall health are equally important in determining the most appropriate treatment.

At CIMS Bhopal (Career Institute of Medical Sciences), patients receive comprehensive lung cancer care through advanced diagnostics, multidisciplinary expertise, and personalized treatment plans. Early diagnosis and timely intervention remain the most effective ways to improve treatment outcomes and quality of life.

Take the First Step Towards Better Lung Health

If persistent cough, chest pain, coughing up blood, or unexplained weight loss are causing concern, don't delay seeking medical attention. The experienced oncology and pulmonology specialists at CIMS Bhopal are committed to providing accurate diagnosis, compassionate care, and advanced treatment for every stage of lung cancer.

Book a consultation with our specialists today and take the first step toward timely diagnosis and personalized lung cancer care.

Contact CIMS Bhopal

Address: Opposite BHEL Dussehra Maidan, Career College Campus, Govindpura, Bhopal, Madhya Pradesh – 462023. 

Appointment & Emergency: +91 9522301166 

Cancer Helpline: +91 9522982211 

Email: corporate@careerhospital.in